A method for simultaneously regulating cell expression product aggregates, charge heterogeneity and improving yield
By adding taurine and glutathione to the CHO cell culture system, the problem of difficult to simultaneously regulate the aggregate, charge heterogeneity and yield of cell expression products in the prior art is solved, and better product quality and The output is increased, suitable for commercial production of biomedicine.
Patent Information
- Application Number
- CN202410254391.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-06
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-03-06
AI Technical Summary
The prior art is difficult to simultaneously regulate the aggregate, charge heterogeneity and yield of cell-expressed products, resulting in difficulty in meeting the needs of biopharmaceutical companies for product quality and cost control.
Add taurine and glutathione to the CHO cell culture system to regulate the polymer, charge heterogeneity of cell expression products and improve yield. By adding regulators during inoculation through batch feeding, the culture conditions are optimized to achieve Coordinate to promote effect.
At the same time, the polymer expression of the antibody is reduced, the charge heterogeneity is improved, and the yield is improved. Compared with the addition of taurine or glutathione alone, the effect is more significant. The degree of polymer decline is increased by 2.2 times, the main peak is increased by 3.6 times, and the yield is increased by 400% and the output is increased by 100% compared with the addition of taurine or glutathione alone. 1.2 times, suitable for industrial production.
Smart Images

Figure CN118240744B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for simultaneously regulating polymers and charge heterogeneity of cell expression products and improving yield, and belongs to the field of cells. Background Art
[0002] Most of the therapeutic antibodies currently available and under development on the market, as well as some recombinant therapeutic proteins, are expressed by mammalian cells (mainly Chinese hamster ovary cells, or CHO cells). Protein polymer content is one of the key attributes (CQA) of protein drugs and has received increasing attention. The formation of polymers will affect the safety and efficacy of the final product. Protein polymers are generally formed by covalent or non-covalent bonds. Antibody disulfide bonds occur in the endoplasmic reticulum, and the occurrence of redox reactions in the endoplasmic reticulum will directly affect antibody disulfide bonds.
[0003] In addition to polymers, therapeutic antibodies or recombinant proteins also have charge heterogeneity. The main reasons for charge heterogeneity include various chemical degradation mechanisms (such as isomerization, amidation, cleavage and oxidation) and addition reactions (covalent addition or glycosylation addition) occurring at different locations of proteins. The alkaline peak mainly comes from the heterogeneity of C-terminal lysine, methionine oxidation or aspartic acid conversion, and the acidic peak mainly comes from N-sugar terminal sialylation modification, amino acid residue deamidation, etc. These phenomena that cause changes in molecules will have a significant impact on the pH of the molecule and will also have a potential impact on the function of the product.
[0004] In addition to quality control, production is also the most important indicator for biopharmaceuticals. When quality is met, increasing production can significantly reduce costs and increase efficiency. With the continuous development of biopharmaceuticals, the requirements for cost control are getting higher and higher, so increasing production is also the goal of every biopharmaceutical company.
[0005] The regulation of aggregates and charge heterogeneity or yield improvement is mainly improved from the perspective of genes, culture medium component regulation and process regulation. The gene improvement method is relatively complex and the cycle is relatively long. In addition, the safety, complexity and stability of this type of method require a long time to verify and determine, which is not conducive to the approval of biological products. The optimization of culture medium components to improve aggregates is limited by culture medium components, the operation is complicated, and it is difficult to implement aggregates. The improvement by process regulation is relatively small. At present, many studies have found that aggregates or charges can be improved by culture medium additives. For example, adding copper sulfate or β-mercaptoethanol can improve product aggregates, adding flavonoids or adjusting zinc ion concentration can improve protein charge heterogeneity, and increasing the amount of feed can increase protein yield. However, these methods can only adjust one quality attribute or yield, and have almost no effect on the adjustment of another quality attribute.
[0006] The purpose of this patent is to develop a method to simultaneously regulate cell expression product aggregates, charge heterogeneity and increase production. Summary of the invention
[0007] The purpose of the present invention is to provide a method that can simultaneously adjust polymers, charge heterogeneity and increase production, so that products that are concerned about polymers, charge heterogeneity and production can be adjusted by this method to obtain products of better quality and can quickly meet the needs. The present invention has the characteristics of simple process, economical and efficient, and is suitable for industrial production.
[0008] The present invention provides a method for simultaneously regulating aggregates, charge heterogeneity and increasing production, that is, adding taurine and glutathione during inoculation, and simultaneously regulating aggregates, charge heterogeneity and increasing production of CHO cell products. The method can reduce antibody aggregates, improve antibody charge heterogeneity and increase production at the same time, and the method can be applied to improve the quality and increase production of antibody drugs. Compared with the single effects of adding copper sulfate, β-mercaptoethanol and other substances on charge heterogeneity, aggregates or increasing production, the method of the present invention can simultaneously regulate aggregates, charge heterogeneity and increase production.
[0009] In order to solve the defects of the prior art, the present invention provides a method for simultaneously regulating aggregates, charge heterogeneity and increasing production, wherein a regulator is added to the cell culture system to regulate aggregates and charge isomers, and the regulator is taurine and glutathione; preferably, the regulator can also increase production at the same time.
[0010] In some specific embodiments, the cell is a CHO-K1 cell; preferably, the CHO-K1 cell comprises an expression vector of the GS gene, and a foreign gene is inserted downstream of the GS gene.
[0011] In certain specific embodiments, the final concentration of taurine in the cell culture system is 1.34-13.4 mM.
[0012] In certain specific embodiments, the final concentration of glutathione in the cell culture system is 150-300 μM.
[0013] In certain specific embodiments, the final concentration of the regulator in the cell culture system is 13.4 mM taurine and 150 μM glutathione.
[0014] In certain specific embodiments, the method includes adding a modulator when the cells are seeded.
[0015] The above method can be carried out by batch feeding of cells using a chemically defined medium commonly used in the art, and taurine and glutathione are added before inoculation. For example, a chemically defined CHO medium is used and cultured in a batch feeding manner.
[0016] In certain specific embodiments, the culture conditions of the method are 36.5°C, 5-8% CO2, 110-130 rpm and 80% humidity.
[0017] In some specific protocols, the temperature is lowered to 31-34° C. on the fifth day of culture.
[0018] The present invention also provides a regulator, which is taurine and glutathione.
[0019] The present invention also provides the use of the regulator in regulating the polymers and charge heterogeneity of cell expression products and improving the yield in cell culture.
[0020] The raw materials and reagents described in the present invention are all commercially available.
[0021] Beneficial effects:
[0022] The present invention adds taurine and glutathione simultaneously in the CHO cell culture system, which can reduce the polymer expression of the antibody, reduce the content of the acidic isomer of the antibody, and increase the yield of the antibody. The effects produced are as follows:
[0023] (1) Effect on aggregates: The expression of aggregates decreased by 6.5%, and the main peak increased by 6.4%;
[0024] (2) Effect on charge isomers: the acid peak decreased by 6.4%, the base peak decreased by 4.8%, and the main peak increased by 11.2%;
[0025] (3) Impact on yield: yield increased by 0.79 g / L.
[0026] Compared with the addition of taurine or glutathione alone, the simultaneous addition of taurine and glutathione has a synergistic effect on aggregates, charge isomers and yield, which increases the decrease in aggregates by 2.2 times and the increase in the main peak by 2.6 times; in terms of charge isomers, the decrease in the acidic peak content increases by 1.3 times and the increase in the main peak increases by 3.6 times; at the same time, the yield increases by 1.2 times.
[0027] In general, the present invention is simple to operate, low in cost, and suitable for the commercial production of various therapeutic antibodies or biosimilar drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 The effect of taurine on the growth and viability of CHO cells;
[0029] Figure 2 The effect of taurine on the charge heterogeneity of CHO cell products;
[0030] Figure 3 The effect of taurine on the product yield of CHO cells;
[0031] Figure 4 The effect of glutathione on the aggregates of CHO cell products;
[0032] Figure 5 The effect of glutathione on the product yield of CHO cells;
[0033] Figure 6 The effect of taurine + glutathione on the aggregates of CHO cell products;
[0034] Figure 7 The effect of taurine + glutathione on the charge heterogeneity of CHO cell products;
[0035] Figure 8 The effect of taurine + glutathione on the product yield of CHO cells. DETAILED DESCRIPTION
[0036] The present invention is further described and illustrated below in conjunction with specific examples, but the present invention is not limited to the scope of the examples. Experimental methods without specific conditions in the following implementation cases are carried out according to conventional methods and conditions, or selected according to the instructions.
[0037] The experimental materials used in the following examples are as follows:
[0038] The cells used in the following examples are CHO-K1 cells, which are from Merck and have a product number of CHOGS-1VL;
[0039] Taurine and glutathione used in the following examples were purchased from Sigma, with product numbers SMB00177-1MG and PHR1359-500MG, respectively.
[0040] Example 1: Effect of taurine on CHO cell expression products
[0041] The specific implementation methods are as follows:
[0042] 1.1 Cell culture
[0043] After cell recovery and expansion for 3 to 4 times, the cells were cultured at 0.5 × 10 6cells / mL was inoculated into the chemically defined basal medium CHO MaxX (Cat. No. MB1113.102), with an initial culture volume of 30 mL and a shake flask volume of 125 mL. The culture conditions were: 36.5°C, 125 rpm, 5% CO2, 80% humidity, and the temperature was lowered to 33°C on the fifth day. The cell viability dropped below 80% or the culture was terminated on D14.
[0044] Taurine experimental group: taurine was added during cell inoculation; the final concentrations were 6.7 mM, 13.4 mM and 19.1 mM, respectively.
[0045] Control group: no additives were added.
[0046] 1.2 Detection methods and instruments
[0047] The expression level of monoclonal antibodies in the supernatant was detected by ProA-HPLC (Protein A-High Performance Liquid Chromatography). For the detection of aggregates and charge heterogeneity, the supernatant sample first needs to be purified by Protein A affinity. Aggregates are detected by gel exclusion chromatography (SEC) and analyzed by ProA-purified samples. Charge heterogeneity is analyzed by IEC-HPLC (ion exchange-high performance liquid chromatography) method for a portion of the purified samples.
[0048] In this embodiment, the cell viability density is detected using a Beckman cell counter, and nutrients such as glucose and lactic acid are detected using a Cedex biochemical analyzer.
[0049] 1.3 Results
[0050] To analyze the effect of taurine on growth, Figure 1 A and 1B show that there is basically no effect. The effect on charge heterogeneity is analyzed by Figure 2 It can be seen that after adding different taurine, the acid peak and the main peak changed compared with the control group, but the change was the largest after adding 13.4mM taurine, with the acid peak decreasing by 4.9% and the main peak increasing by 3.1%, indicating that taurine can improve the charge heterogeneity of monoclonal antibodies; the effect of adding taurine on the expression level was analyzed. Figure 3 It can be seen that the expression level has basically not changed.
[0051] Example 2: Effect of glutathione on CHO cell expression products
[0052] The specific method is the same as Example 1, except that glutathione is added to the culture medium during inoculation; the final concentrations are 100 μM, 150 μM and 200 μM, respectively.
[0053] The effect of glutathione on the polymer was analyzed by Figure 4It can be seen that after adding glutathione, different concentrations have an effect on the decrease of aggregates, but the final concentration of 150μM has the best effect. The expression of antibody aggregates decreased by 3%, and the main peak (monomer) increased by 2.5%. The effect of adding glutathione on the expression was analyzed. Figure 5 Analysis showed that adding different concentrations of glutathione had little effect on the expression level, indicating that adding glutathione could improve the aggregates of CHO cell expression products without affecting their expression level.
[0054] Example 3: Effect of taurine + glutathione on CHO cell expression products
[0055] The specific method is the same as Example 1, except that taurine glutathione is added to the culture medium at the same time during inoculation; the final concentrations are 13.4 mM and 150 μM, respectively.
[0056] The effect of simultaneous addition of taurine and glutathione on the polymer was analyzed by Figure 6 The expression of polymer decreased by 6.5%, and the main peak (monomer) increased by 6.4%. The effect on charge isomers was analyzed. Figure 7 Analysis showed that when taurine and glutathione were added simultaneously, the acid peak decreased by 6.4%, the base peak decreased by 4.8%, and the main peak increased by 11.2%. Analysis of the effect of adding taurine and glutathione simultaneously on the yield showed that Figure 8 Analysis showed that the yield was increased by 1.2 times.
[0057] In summary, in Examples 1 to 3, the addition of 13.4 mM taurine can reduce the acidic peak content and increase the main peak ratio without affecting the yield; the addition of 150 μM glutathione alone can reduce the aggregate content and increase the main peak ratio; the simultaneous addition of 13.4 mM taurine and 150 μM glutathione can reduce aggregates, reduce the acidic peak and increase the yield. Compared with the addition of taurine alone, when taurine and glutathione are added simultaneously, the degree of reduction of the acidic peak content is increased from 4.9% to 6.4%, an increase of 1.3 times; the degree of increase of the main peak is increased from 3.1% to 11.2%, an increase of 3.6 times; and the yield is increased by 1.2 times. Compared with the addition of glutathione alone, when taurine and glutathione are added simultaneously, the degree of reduction of aggregates is increased from 3% to 6.5%, an increase of 2.2 times; the degree of increase of the main peak is increased from 2.5% to 6.4%, an increase of 2.6 times; and the yield is increased by 1.2 times. The above results indicate that the simultaneous addition of taurine and glutathione has a synergistic effect on charge heterogeneity, changes in aggregate content and yield.
[0058] Table 1 Effects of additives on charge heterogeneity, aggregates and yield
[0059]
[0060] -No impact
[0061] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A method for simultaneously regulating the polymers, charge heterogeneity and yield of cell expression products, characterized in that: A regulator is added to the cell culture system, wherein the regulator is taurine and glutathione, the final concentration of the taurine is 13.4 mM, and the final concentration of the glutathione is 150 μM; and the cell is a CHO-K1 cell.
2. The method according to claim 1, characterized in that Modulators are added to the culture medium at the time of cell seeding.
3. The method according to claim 1, characterized in that The product is selected from monoclonal antibody and bispecific antibody.
4. The method according to claim 1, characterized in that The product is selected from recombinant proteins.
5. The method according to claim 1, characterized in that The culture conditions of the cells are: 36.5° C., 110-130 rpm, 5-8% CO 2 , and 80% humidity.
6. The method according to claim 5, characterized in that On the fifth day of cultivation, the temperature was lowered to 31-34°C.
7. A regulator for regulating cell expression product polymers, charge heterogeneity and increasing yield, characterized in that: The regulators are taurine and glutathione, the final concentration of taurine added is 13.4 mM, and the final concentration of glutathione added is 150 μM; the cells are CHO-K1 cells.
